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The aim of this study was to investigate the immunomodulatory properties of cell wall
extract  from Enterococcus faecalis CECT7121, measuring the induction of cytokines TNF-a,
IL-6,  IL-10 and IL-12 from human peripheral blood mononuclear cells (PBMCs). Cell wall
extract  was prepared from their growth in brain heart infusion broth (18 h, 35 ◦C). Subse-
quently,  toxicity of the  obtained cell wall extract was tested in Balb-C mice. PBMCs were
isolated  from buffy coats at the Blood Transfusion Service of Hospital Ramón Santamarina
(Tandil,  Argentina). PBMCs were purified using standard Ficoll-Paque gradient centrifuga-
tion.  Aliquots of purified leukocytes were incubated at 37 ◦C for 24 h  with heat-killed E.
faecalis  CECT7121 and cell  wall extract. Concentrations of IL-6, TNFa, IL-10 and IL-12 (p70)
were  measured by solid phase sandwich ELISA. Changes in appearance and behavior of mice
were evidenced only in the group with the maximal concentration of wall cell extract used
(10,000  mg). Cell wall extract and heat-killed E. faecalis CECT7121 induced the  production
of  significantly higher amounts of Il-12, IL-6, TNF-a and IL-10 cytokines compared to the
nonstimulated  PBMCs. These findings provide helpful information on immunomodulationactivity  by  cell wall extract in sight of the application of this compound in controlling certain
infectious  diseases.
disease.  The probiotic approach represents an alternative
© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDmergence of multi-drug resistant strains and infectious
isease outbreaks caused by resilient strains are the most
mportant  global issues related to treatment of invasive
1nfections. An immune response imbalance can occur in sys-
emic  infections; therefore it is important to achieve a  balance
etween  pro- and anti-inflammatory cytokines.2
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strategy for prevention and treatment of inflammatory dis-
eases.  Probiotic microorganisms can act as modulators of the
systemic  and mucosal immune responses. Previous studies
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have shown that different bacterial strains can exert their
probiotic  properties by influencing the host’s immune sys-
tem,  thereby modulating immune responses. It has been
proven  that probiotic strains of lactic acid bacteria enhance
the  phagocytic and NK activities and induce maturation of
dendritic  cells.3
Though therapeutic use of probiotics has been observed
for  more  than a century, safety issues have not been defini-
tively  clarified yet. There are  case reports of complications
with specific bacteria therapy; this suggests the possibility
of  considering a revision of probiotic safety aspects.4–6 Oth-
erwise,  in  individuals with a pre-existing structural heart
disease  or  severe immunodeficiency, lactobacilli can translo-
cate  and cause severe infection.7
In contrast, non-viable microorganisms or microbial cell
extracts  could eliminate shelf-life problems and reduce the
risks  of microbial translocation and infection. Non-viable
material of microbial origin can interact directly with the
host  through the capacity of human cells to recognize spe-
cific  bacterial components or products, giving rise to responses
that  involve the immune system. Specialized conserved pat-
tern  recognition receptors on host cell membranes, such as
Toll-like  receptors (TLRs) and the nucleotide-binding domain
proteins  (NOD), are the primary sensors of the innate immune
system  and recognize microbe-associated molecular pat-
terns,  including peptidoglycan. Previous studies have shown
that  cell-wall components of lactic acid bacteria stimulate
the  immune system through interaction with the leuko-
cyte  pattern recognition receptors, TLRs. Lipopolysaccharide
(LPS) of Gram-negative bacteria induces production of pro-
inflammatory cytokines tumor necrosis factor alpha (TNF-a)
and  interleukin-6 (IL-6), as well as IL-10, which is known to
inhibit  the synthesis of the former two cytokines. These pro-
inflammatory cytokines contribute to defense mechanisms
of  the host in response to bacterial colonization or invasion,
and  when secreted in excess, they may induce pathological
disorders of immune origin. IL-12 and IL-10 are important
immunomodulatory cytokines produced by cells of the innate
immune  system. Both compounds are secreted by mono-
cytes/macrophages in response to bacterial products which
have  opposite effects on the immune system. Functional IL-12
is  a heterodimer of 70  kD (p70) formed by the  covalent union of
two  chains denominatedp40 (40 kD) and p35 (35 kD). IL-12 acti-
vates  cytotoxicity and gamma  interferon secretion by T cells
and  NK cells, whereas IL-10 inhibits these functions.8
In recent years, a  non-pathogenic strain, Enterococcus fae-
calis  CECT7121, has been proposed as immunomodulator.
When peritoneal macrophages were stimulated with heat-
killed  E. faecalis CECT7121, synthesis of IL-6, TNFa and IL-12
were  induced in a  concentration-dependent fashion, whereas
synthesis  of IL-10 was  induced only by the highest concentra-
tion  5.0 × 107 CFU/mL of E.  faecalis CECT7121. When these cells
were  stimulated with Salmonella serotype Enteritidis, signifi-
cantly  higher levels of TNFa, IL-6, IL-10 and IL-12 were detected
than  in the control cells. E. faecalis CECT7121 modulates the
innate  immune system response by inducing the synthesis of
IL-12  and IL-10; two crucial cytokines for the maintenance of
the  host’s immune homeostasis.9–11
In other in vivo experiments, using BALB-C mice, the
adjuvant properties of E. faecalis CECT7121 have been 1 4;1 8(5):551–555
demonstrated, as well as its influence on the Th1/Th2 polar-
ization  during the specific immune response generated by the
immunization  with the vaccine DTPw, diphtheria, tetanus and
whole-cell  Bordetella pertussis.12
The aim of this study was to investigate the immunomodu-
latory properties of cell wall extract from E. faecalis CECT7121,
measuring the induction of cytokines TNF-a, IL-6, IL-10 and IL-
12 from human peripheral blood mononuclear cells (PBMCs).
In  order to obtain bacterial suspensions, E.  faecalis
CECT7121 was  grown in brain heart infusion broth (Labora-
torio  Britania, Argentina) at 35 ◦C for 18 h. After incubation,
cultures were harvested by centrifugation (10,000 × g, 15  min)
and  extensively washed with sterile saline solution. Standard
growth  curves were prepared by plotting the OD620 vs.  agar
plate  counts of serially diluted cultures. Bacterial suspensions
were  prepared in RPMI (Gibco, US) plus 10% fetal calf serum
(Gibco,  US) for PBMCs experiments. Aliquots of these suspen-
sions  were  frozen and stored at −70 ◦C until used. For PMBCs
experiments, a 5.0 × 107 CFU/mL-heat-killed E. faecalis suspen-
sion  was  selected in agreement with Castro et al.9 Extraction
of  cell wall from E. faecalis CECT7121 was  carried out as fol-
lows:  a  fresh bacterial culture in brain heart infusion broth
(35 ◦C, 18 h)  was  submitted to centrifugation at 10,000 ×  g  for
15  min  and then washed with sterile saline solution. Bacte-
ria  were suspended in  25 mM  Tris–HCl, pH 7.4 with 1 mM
EDTA-Na2 pre-cooled and were submitted to  five sonication
cycles for 15  min  each, with 2 min  intervals on ice in a sonica-
tor  1510 (Braun Biotech Inc., US) at 100 W output. Cells were
separated by centrifugation at 12,000 ×  g  for 10 min, and sus-
pended  in 25  mM  Tris–HCl (pH 7.4), 8 mM  MgCl2,  1 mg/mL of
RNase  A (Sigma, USA) and 1 mg/mL of DNase I (Sigma). The
sample  was incubated at 37 ◦C for 3 h,  washed twice, and
suspended in saline solution. Afterwards, it was  heated to
100 ◦C with 1.0 (wt.%/vol.%) sodium dodecyl sulfate (SDS) for
4  h, centrifuged three times at 12,000 × g  for 10  min, dialyzed
against 1 L of 1% bovine serum albumin in distilled water,
and  resuspended in sterile saline solution. Obtained material
was  lyophilized; dry weight was  determined and thenceforth
called PEF7121.
Potential toxicity of PEF7121 was  evaluated using BALB-C
mice  (n = 8/group) injected intraperitoneally (IP) with 0.5 mL
of  the following amounts of PEF7121; group A: 1000 mg, group
B:  2000 mg, group C: 5000 mg and group D: 10,000 mg. Control
animals were inoculated with 0.5 mL  sterile saline solution.
Clinical appearance of mice was  monitored after the chal-
lenge  with PEF7121 and subjective aspects of behavior were
recorded  according to the General Health Score scale which
takes  into account the criteria of Gill et  al.13 Briefly appear-
ance  and behavior aspects are as follows: S5: bright eyed and
alert,  a  smooth coat with a  sheen, responds to stimulus, shows
interest  in  environment; S4: fur slightly ruffled, a  loss of sheen
of  the coat, mouse remains alert and active; S3: fur noticeably
ruffled, parts of coat form clumps, not as alert or active, less
interested in environment outside of cage, signs of hyperven-
tilating  when handled; S2: hunched over and lethargic, little
interest  shown in environment, fur clumped; and S1: nonre-
active  to  stimulus, fur has a  “bottle brush” appearance (i.e.,
standing  on end), hunched over preferring to sleep than react
to  environment, cold at touch, paws cold. The animals were
observed  along for 15 days.
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Fig. 1 – General Health Score in  BALB-C mice injected intraperitoneally with cell wall extract of E. faecalis CECT7121
(PEF7121). (A) 5000 mg PEF7121 score 5, bright eyed and alert, a smooth coat with sheen, responds to stimulus, shows
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PBMCs were  isolated from buffy coats obtained from the
lood  Transfusion Service of the Hospital Ramón Santamarina
Tandil city, Argentina). To minimize inter-individual varia-
ion,  all experiments were performed with cells obtained from
our  blood donors. The study was  performed in accordance
ith the Declaration of Helsinki and the local Ethics Commit-
ee.
PBMCs  were  purified using standard Ficoll-Paque gra-
ient  centrifugation according to the instructions of the
anufacturer (Amersham Biosciences, Piscataway, USA).
fter  washing, the cells were  resuspended in RPMI 1640
edium containing 10% heat-inactivated fetal calf serum,
 mM l-glutamine (Sigma, USA), 100 U/mL of penicillin, and
00  mg/mL  of streptomycin (Gibco, USA) at a final concen-
ration  of 106 cells/mL. Aliquots (2 mL)  of purified leukocytes
106 cells/mL) were  incubated in 24-well plates at 37 ◦C for 24 h
ith  stimulators, in  the presence of 5% CO2.  Heat-killed E. fae-
alis  CECT7121 (5.0 × 107 CFU/mL) and PEF7121 (at the minimal
ontoxic  concentration resulting from the in  vivo experiment)
ere  used to stimulate PBMCs. Purified lipopolysaccharide
LPS) from Escherichia coli O111:B4 (Sigma, USA) was  used at
 concentration of 1 mg/mL  as a  positive control. Nonstimu-
ated PBMCs were  also evaluated as controls of basal cytokine
roduction. Every sample was  assayed in triplicate, and each
xperiment  was  performed with mononuclear cells from four
onors.  Cell culture supernatants were  harvested and stored
t  −20 ◦C until cytokines were  analyzed.
Concentrations  of IL-6, TNFa, IL-10 and IL-12 (p70) in
ulture supernatants of PBMCs were measured by solid
hase  sandwich ELISA (enzyme-linked immunosorbent assay)
mploying commercial kits (Pharmingen, CA, USA) according
o  the manufacturer’s instructions. Cytokine concentrations
ere  obtained from standard curves. Analytical sensitivities
ere  2.0 pg/mL for TNF-a, 2.2 pg/mL for IL-6, 4.0 pg/mL for
l-12  (p70) and 2.0 pg/mL for IL-10. Data were expressed as
he  mean ± standard error for mean (SEM). Results were ana-
yzed  by analysis of variance – one-way ANOVA followed by
he  Dunnett’s multiple comparisons test (several parame-
ers  against the control group) or the Student’s t-test (two
arameters) using GRAPHPAD PRISM ver. 4.00 for Windows
GraphPad Software, USA). For toxicity of PEF7121 – chal-
enged  mice were  compared between groups using log rank
est.ly ruffled, a loss of sheen of the coat, mouse remains alert
Changes  in the appearance and behavior of mice were  first
evidenced on day 2 post-challenge in  the group D and the
general  health score of these animals was S4. The control
and groups A, B and C obtained the highest score throughout
the  study (S5). At the end of the  experiment (day 15 post-
challenge) 100% of the animals had survived (Fig. 1).
Results  of the effects of PEF7121 on cytokine production by
PBMCs  are shown in  Fig. 2.
PEF7121 and heat-killed E.  faecalis CECT7121 induced the
production of significantly higher amounts of both Th1-type
cytokines,  IL-12, IL-6 and TNF-a and the regulatory cytokine
IL-10  compared to the nonstimulated PBMCs (p < 0.01).
The mean cytokine production in stimulated PBMCs was  as
follows:  (a) heat-killed E. faecalis CECT7121:868.5 pg/mL for IL-
10, 655.8 pg/mL for TNF-a, 704.0 pg/mL for IL-6 and 976.8 pg/mL
for  IL-12; (b) PEF7121:942.6 pg/mL for IL-10, 731.6 pg/mL for
TNF-a,  504.9 pg/mL for IL-6 and 1061.3 pg/mL for IL-12; (c)
LPS:  280.9 pg/mL for IL-10, 108.1 pg/mL for TNF-a, 236.4 pg/mL
for  IL-6 and 125.7 pg/mL for IL-12. There were  no significant
differences in PBMCs stimulation of IL-10, IL-12 and TNFa
between  heat-killed cells and PEF7121 (p > 0.05), but the IL-6
induction  was  superior with heat-killed E. faecalis CECT7121
(p  < 0.05). After 24 h PEF7121 induced the release of ILs and
TNF-a  in significantly higher amounts than those achieved by
LPS-induction.
In this study, ability of cell wall extract of the probiotic
strain E. faecalis CECT7121 to stimulate production of pro- and
anti-inflammatory cytokines using activated human mono-
cyte  model was investigated. Effect of heat-killed cells on
cytokine  production was  confirmed by PEF7121, indicating
that  bacterial cell envelope components are important in
determining  immunostimulating activities of probiotic bacte-
ria.  It was proven that PEF7121 is a  potent inducer of TNF-a,
IL-6  and IL-12 release from human PBMCs in  quantities even
higher  than those induced with LPS. The significant differen-
tial  effects detected in IL-6 stimulation between the use of
heated  cells and cell wall extract as stimulants might have
been  due to alteration of PBMCs’ receptors during the  proce-
dure  of sonication. In addition, other important compounds
for  immune stimulation could have been lost along during the
obtainment  of PEF7121.
Induction  of pro-inflammatory cytokines could indicate
that  this extract can stimulate nonspecific immune responses.
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Fig. 2 – Cytokine production by peripheral blood mononuclear cells (PBMCs) stimulated with cell wall extract PEF7121.
Concentration of IL-10 (A), TNFa (B), IL-6 (C) and IL-12 (D)  by PBMCs (area under the curve of mean ± SE) after incubation
with  heat killed E. faecalis CECT7121, cell wall extract PEF7121 and LPS (**p < 0.01, ANOVA, Dunnett’s post-test). Triplicate
intermeasures were  determined in four independent assays. IL: 
Induction of IL-10 by PEF7121 is expected to participate in
the  down-regulation of inflammation, since this cytokine can
inhibit the functions of macrophages and T cells and pro-
mote  the development of regulatory T cells. Therefore, it is
important  to achieve a  balance in the profiles of pro- and anti-
inflammatory cytokines. Outcomes of this study indicate that
PEF7121  would be able to either suppress or stimulate inflam-
matory  responses.
The  use of non-viable material of microbial origin has
a  remarkable advantage over probiotics, since it allows the
generation of safer and more  stable products. Until now,
immunological studies of E. faecalis CECT7121, or its non-
viable  material such as cell wall extract, have not been
performed in  a  human cell model. For this purpose PBMCs
were  used, which are  easily available and express TLR2 and
TLR4  receptors as  well as  CD14 which have shown to medi-
ate  immune response against microbial components such as
peptidoglycan.14
In previous studies, it was  demonstrated that E. faecalis
CECT7121 implants itself and persists in  the intestine of
BALB/c  mice stimulating the  innate immune system. It was
also  proven that peritoneal macrophages from mice intragas-
trically  (IG) pre-treated with E. faecalis CECT7121 had higher
capacity  for responding to certain microorganisms by secret-
ing  higher levels of inflammatory cytokines.9 Finally, it was
observed  that the  IG administration of E. faecalis CECT7121
exerted an adjuvant effect acting as a  Th1 modulator in the
anti-tetanus and anti-diphtheria immune responses at the
systemic  level.12leukin; LPS: lipopolysaccharide; TNF: tumor necrosis factor.
Results of this study further suggest that surface structures
of  lactic acid bacteria are important in determining immune
responses.  Inflammatory interleukins’ stimulation patterns
shown  by PEF7121 are  in line with those observed by Medina
et  al.15 These authors concluded that cell-surface compo-
nents  of Bifidobacterium longum ATCC 15707 and BIF53 strain
induced  a  significant production of both Th1-type cytokines,
IL-2  and IFN-g. Although in discordance with PEF7121, those
components have not affected IL-10. Induction of IL-10 was
also  found by Shida et al.16 using Lactobacillus casei, strain
Shirota. In vitro, several species of lactobacilli have shown
to  trigger the release of IL-6 and TNF-a from PBMCs in
amounts comparable to  those induced by E. coli.17 Recent stud-
ies  have suggested that probiotic Lactobacillus strains may  have
anti-inflammatory activities that directly modulate the host
immune  system.18Also, previous studies have demonstrated
inflammatory cytokines’ induction by cell components of lac-
tic acid bacteria.19,20
According to  other authors, bacteria show different
immunostimulation profiles. Each probiotic strain has unique
and  different properties and probiotic effects of a specific
strain  must not be  extrapolated to others.3,19 Comparison
between reference strains, human isolates and commercial
probiotics has shown that there is a  strain-specific pattern of
cytokine  production, particularly for IL-10 and TNF-a.15 Some
of  these features are more  desirable than others, being neces-
sary  for a careful selection of these probiotic strains.
In this study, a  role of immnomodulator and promoter
of innate defenses is suggested for PEF7121.These findings
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